BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21539811)

  • 21. Isolation and characterization of two evolutionarily conserved murine kinases (Nek6 and nek7) related to the fungal mitotic regulator, NIMA.
    Kandli M; Feige E; Chen A; Kilfin G; Motro B
    Genomics; 2000 Sep; 68(2):187-96. PubMed ID: 10964517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitogen-activated protein kinase p38 and retinoblastoma protein signalling is required for DNA damage-mediated formation of senescence-associated heterochromatic foci in tumour cells.
    Zhang Y; Gao Y; Zhao L; Han L; Lu Y; Hou P; Shi X; Liu X; Tian B; Wang X; Huang B; Lu J
    FEBS J; 2013 Sep; 280(18):4625-39. PubMed ID: 23859194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyploidy Formation in Doxorubicin-Treated Cancer Cells Can Favor Escape from Senescence.
    Mosieniak G; Sliwinska MA; Alster O; Strzeszewska A; Sunderland P; Piechota M; Was H; Sikora E
    Neoplasia; 2015 Dec; 17(12):882-893. PubMed ID: 26696370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ATM-deficient human fibroblast cells are resistant to low levels of DNA double-strand break induced apoptosis and subsequently undergo drug-induced premature senescence.
    Park J; Jo YH; Cho CH; Choe W; Kang I; Baik HH; Yoon KS
    Biochem Biophys Res Commun; 2013 Jan; 430(1):429-35. PubMed ID: 23178571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secreted protein acidic and rich in cysteine-induced cellular senescence in colorectal cancers in response to irinotecan is mediated by P53.
    Chan JM; Ho SH; Tai IT
    Carcinogenesis; 2010 May; 31(5):812-9. PubMed ID: 20164124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells.
    Jackson JG; Pereira-Smith OM
    Mol Cell Biol; 2006 Apr; 26(7):2501-10. PubMed ID: 16537896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of NEK6 in tumor promoter-induced transformation in JB6 C141 mouse skin epidermal cells.
    Jeon YJ; Lee KY; Cho YY; Pugliese A; Kim HG; Jeong CH; Bode AM; Dong Z
    J Biol Chem; 2010 Sep; 285(36):28126-33. PubMed ID: 20595392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TNF-alpha promotes Doxorubicin-induced cell apoptosis and anti-cancer effect through downregulation of p21 in p53-deficient tumor cells.
    Cao W; Chi WH; Wang J; Tang JJ; Lu YJ
    Biochem Biophys Res Commun; 2005 May; 330(4):1034-40. PubMed ID: 15823547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doxorubicin induces cell senescence preferentially over apoptosis in the FU-SY-1 synovial sarcoma cell line.
    Joyner DE; Bastar JD; Randall RL
    J Orthop Res; 2006 Jun; 24(6):1163-9. PubMed ID: 16705698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cathepsin D and eukaryotic translation elongation factor 1 as promising markers of cellular senescence.
    Byun HO; Han NK; Lee HJ; Kim KB; Ko YG; Yoon G; Lee YS; Hong SI; Lee JS
    Cancer Res; 2009 Jun; 69(11):4638-47. PubMed ID: 19487283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human NIMA-related kinase 6 is one of the Fe65 WW domain binding proteins.
    Lee EJ; Hyun SH; Chun J; Kang SS
    Biochem Biophys Res Commun; 2007 Jul; 358(3):783-8. PubMed ID: 17512906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective sensitization of retinoblastoma protein-deficient sarcoma cells to doxorubicin by flavopiridol-mediated inhibition of cyclin-dependent kinase 2 kinase activity.
    Li W; Fan J; Bertino JR
    Cancer Res; 2001 Mar; 61(6):2579-82. PubMed ID: 11289134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53.
    Fang L; Igarashi M; Leung J; Sugrue MM; Lee SW; Aaronson SA
    Oncogene; 1999 May; 18(18):2789-97. PubMed ID: 10362249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity.
    Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
    Clin Cancer Res; 2003 Jul; 9(7):2856-65. PubMed ID: 12855666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In situ DOX-calcium phosphate mineralized CPT-amphiphilic gelatin nanoparticle for intracellular controlled sequential release of multiple drugs.
    Li WM; Su CW; Chen YW; Chen SY
    Acta Biomater; 2015 Mar; 15():191-9. PubMed ID: 25542535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1.
    Vigneron A; Roninson IB; Gamelin E; Coqueret O
    Cancer Res; 2005 Oct; 65(19):8927-35. PubMed ID: 16204065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
    Ling YH; el-Naggar AK; Priebe W; Perez-Soler R
    Mol Pharmacol; 1996 May; 49(5):832-41. PubMed ID: 8622633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E2F-1 is a critical modulator of cellular senescence in human cancer.
    Park C; Lee I; Kang WK
    Int J Mol Med; 2006 May; 17(5):715-20. PubMed ID: 16596252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NIMA-related kinases 6, 4, and 5 interact with each other to regulate microtubule organization during epidermal cell expansion in Arabidopsis thaliana.
    Motose H; Hamada T; Yoshimoto K; Murata T; Hasebe M; Watanabe Y; Hashimoto T; Sakai T; Takahashi T
    Plant J; 2011 Sep; 67(6):993-1005. PubMed ID: 21605211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.